Page last updated: 2024-09-04

zm 230487 and Edema

zm 230487 has been researched along with Edema in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nourshargh, S; Walsh, DT; Weg, VB; Williams, TJ1
Hellewell, PG; Teixeira, MM1
Hellewell, PG; Macari, DM; Teixeira, MM1

Other Studies

3 other study(ies) available for zm 230487 and Edema

ArticleYear
Substance P-induced inflammatory responses in guinea-pig skin: the effect of specific NK1 receptor antagonists and the role of endogenous mediators.
    British journal of pharmacology, 1995, Volume: 114, Issue:7

    Topics: Animals; Antibodies, Monoclonal; Biphenyl Compounds; Chlorpheniramine; Dihydropyridines; Dose-Response Relationship, Drug; Edema; Female; Guinea Pigs; Imidazoles; Indoles; Inflammation; Isoindoles; Neurokinin-1 Receptor Antagonists; Pyrans; Quinolones; Skin; Substance P; Time Factors

1995
Effect of a 5-lipoxygenase inhibitor, ZM 230487, on cutaneous allergic inflammation in the guinea-pig.
    British journal of pharmacology, 1994, Volume: 111, Issue:4

    Topics: Animals; Arachidonic Acid; Edema; Eosinophils; Guinea Pigs; Leukotriene B4; Lipoxygenase Inhibitors; Male; Passive Cutaneous Anaphylaxis; Pyrans; Quinolones

1994
Priming of eosinophil recruitment in vivo by LPS pretreatment.
    Journal of immunology (Baltimore, Md. : 1950), 1996, Aug-15, Volume: 157, Issue:4

    Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Azepines; CD18 Antigens; Chemotactic Factors, Eosinophil; Chemotaxis, Leukocyte; Complement C5a, des-Arginine; Cycloheximide; Drug Synergism; Edema; Eosinophilia; Eosinophils; Female; Guinea Pigs; Immunoglobulin G; Interleukin 1 Receptor Antagonist Protein; Leukocyte Count; Leukotriene B4; Lipopolysaccharides; Lipoxygenase Inhibitors; Neutrophils; Passive Cutaneous Anaphylaxis; Platelet Activating Factor; Protein Synthesis Inhibitors; Pyrans; Quinolones; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Recombinant Fusion Proteins; Sialoglycoproteins; Skin; Triazoles; Zymosan

1996